Pharmacology - lipid lowering drugs Flashcards
the main aim of lipid lowering drugs is to reduce..
a. VLDL
b. cholesterol
c. triglycerides
d. HDL
e. LDL
e.LDL
what is the most significant lifestyle intervention for hypertension?
a. achieve healthy body weight
b. stop smoking
c. healthy diet
d. restrict salt
b. stop smoking
what is the most significant lifestyle intervention for lipid lowering?
a. achieve healthy body weight
b. stop smoking
c. healthy diet
d. restrict salt
c.healthy diet
what diet is used to lower lipids?
a. portfolio diet
b. DASH diet
c. mediterranean diet
a.portfolio diet
wholegrain foods, minimising dietary fat, reducing sugar intake, 5 a day, seeds/legumes and 2 portions of fish are key for what?
a. reducing hypertension
b. reducing cardiac risk
c. reducing lipids
c.reducing lipids
what are HMG-CoA reductase inhibitors commonly known as?
a. ACE inhibitors
b. ARBs
c. ARNIS
d. CCB
e. statins
e.statins
how does inhibiting HMG-coA reductase lead to a reduced circulating LDL?
inhibit HMG-CoA reductase
reduced cholesterol synthesis
up regulation of LDL receptors
movement of LDL into cells
reduced circulating LDL
inhibiting HMG-coA reductase has what effect on the amount of LDL receptors?
a. increase
b. decrease
a.increase
which is the most potent statin?
a. rosuvastatin
b. atorvastatin
c. simvastain
d. pravastatin
a.rosuvastatin
which is the second most potent statin?
a. rosuvastatin
b. atorvastatin
c. simvastain
d. pravastatin
b.atorvastatin
which is the third most potent statin?
a. rosuvastatin
b. atorvastatin
c. simvastain
d. pravastatin
c.simvastain
which is the least potent statin?
a. rosuvastatin
b. atorvastatin
c. simvastain
d. pravastatin
d.pravastatin
when are statins given?
a. morning
b. night
b.night
which two statins are hydrophillic?
a. Rosuvastatin and pravastatin
b. simvastain and pravastatin
c. atorvastatin and simvastatin
a.Rosuvastatin and pravastatin
muscle pain, GI disturbance and liver enzyme abnormalities are adverse effect of which lipid lowering drugs?
a. statins
b. PCSK9 inhibitors
c. fibrates
a.statins
how does ezetimibe work?
a.inhibit HMG-CoA reductase reduced cholesterol synthesis up regulation of LDL receptors movement of LDL into cells reduced circulating LDL
b. inhibit absorption of cholesterol into the small intestine
cannot combine with glycerol to be made into a chylocmicron by NPC1l1
b. inhibit absorption of cholesterol into the small intestine
cannot combine with glycerol to be made into a chylocmicron by NPC1l1
GI disturbance and headache are ide effects of which lipid lowering drug?
a. statins
b. ezetimibe
c. fibrates
b.ezetimibe
how to PCSK9 inhibitors work?
a.inhibit HMG-CoA reductase reduced cholesterol synthesis up regulation of LDL receptors movement of LDL into cells reduced circulating LDL
b. inhibit absorption of cholesterol into the small intestine
cannot combine with glycerol to be made into a chylocmicron by NPC1l1
c.monoclonal antibodies against proprotein convertase substilin - like/kexin-9
cant destroy LDL receptor
more LDL taken into cell
less LDL in blood
c.monoclonal antibodies against proprotein convertase substilin - like/kexin-9
cant destroy LDL receptor
more LDL taken into cell
less LDL in blood
how are PCSK9 inhibitors given?
a. monthly SC
b. monthly IM
c. monthly oral
a.monthly SC
-umab
pcsk-9 inhibitor
nasopharygitis, back pain and flu like symptoms are associated with which lipid lowering drug?
a. fibrate
b. statins
c. pcsk9 inhibitor
d. ezetimibe
c.pcsk9 inhibitor
how do fibrates work?
a.inhibit HMG-CoA reductase reduced cholesterol synthesis up regulation of LDL receptors movement of LDL into cells reduced circulating LDL
b. inhibit absorption of cholesterol into the small intestine
cannot combine with glycerol to be made into a chylocmicron by NPC1l1
c.monoclonal antibodies against proprotein convertase substilin - like/kexin-9
cant destroy LDL receptor
more LDL taken into cell
less LDL in blood
d. activate PPARa nucelar transcription factor in liver and muscle, increased transcription of genes for lipoprotein lipase and apo-A1 /apo -A5, reduce VLDL and triglycerides
d. activate PPARa nucelar transcription factor in liver and muscle, increased transcription of genes for lipoprotein lipase and apo-A1 /apo -A5, reduce VLDL and triglycerides
which drug mainly reduces VLDL so triglycerides?
a. fibrate
b. statins
c. pcsk9 inhibitor
d. ezetimibe
a.fibrate
what do fibrates increase transcription of by activating tf PPARa?
a. liprotein lipase, apo A1, apo- A5
b. liprotein lipase, apo A1, apo C11
a. ldl receptor, apo A1, apo- A5
a.liprotein lipase, apo A1, apo- A5